Rapid Microbiology Testing Market by Method, End-user and Geography - Forecast and Analysis 2023-2027

Rapid Microbiology Testing Market Forecast 2023-2027

The rapid microbiology testing market size is forecast to increase by USD 2.48 billion, at a CAGR of 9.31% between 2022 and 2027. The market is witnessing significant growth propelled by several key factors. These include the escalating incidence of infectious diseases and cancer, which underscores the critical need for swift and accurate microbiology testing solutions. Additionally, the aging population demographic is driving demand, as older individuals are more susceptible to infections and related complications. Furthermore, the prevalence of food-borne diseases is amplifying the urgency for rapid microbiology testing methodologies to ensure food safety and public health. This confluence of factors highlights the essential role of rapid microbiology testing in safeguarding public health and advancing disease diagnostics. It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will the Size of the Rapid Microbiology Testing Market be During the Forecast Period?

To learn more about this report, Download Report Sample PDF

 

The market is experiencing a transformative phase driven by several critical factors. Automation and miniaturization are revolutionizing testing methodologies, enhancing efficiency, and reducing turnaround times. This market expansion is also fueled by heightened detection sensitivity, enabling swift and accurate identification of pathogens and contaminants. Molecular diagnostic techniques are at the forefront, offering precise insights into microbial profiles and antimicrobial resistance patterns, crucial for addressing emerging public health challenges like bioterrorism surveillance. Moreover, as food safety concerns escalate, rapid microbiology testing emerges as a pivotal solution, supported by substantial public and private investments. Despite staffing shortages, advancements in assay reagents, equipment, and microbiology testing services are poised to mitigate challenges, ensuring the delivery of routine tests with unparalleled speed and reliability.

Market Dynamics and Customer Landscape

The market is witnessing significant growth driven by rising concerns over infectious diseases and food safety. Technological advancements, including automation and miniaturization, are enhancing detection sensitivity and streamlining microbiology techniques. With increasing public-private investments, there's a focus on combating antimicrobial resistance and bioterrorism surveillance. Rapid microbiology testing services encompass a wide range of offerings, from assay reagents and equipment to transport media and staffing solutions. Clinical microbiology laboratories are adopting these solutions for routine tests, utilizing swabs and extraction reagents for efficient diagnostics. The market's trajectory underscores its pivotal role in addressing global health challenges. The increasing incidence of infectious diseases and cancer is notably driving the market, although factors such as inadequate healthcare services in developing regions may impede the market. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver 

The increasing incidence of infectious diseases and cancer is the key factor driving the global market. The prevalence of infectious diseases such as tuberculosis, HIV, pneumonia, and malaria has increased. HIV attacks eventually destroy the immune system, resulting in AIDS, although this progression takes years. Thus, the body cannot defend itself against germs and infections as the immune system is compromised.

A compromised immune system makes the individual susceptible to diseases such as tuberculosis and pneumonia. There has been an increase in awareness programs related to infectious diseases such as HIV, cancer, tuberculosis, and pneumonia to encourage preventive healthcare or early diagnosis for improved treatment outcomes. With the global burden of these diseases increasing, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and testing against pathogens is expected to grow significantly during the forecast period.

Significant Market Trends

The rise in food safety concerns is the primary trend in the global market. Individual food products are made up of plants and animals, and they usually contain a variety of microorganisms. Microbes from natural sources may come into contact with and contaminate food during manufacturing and consumption processes. Furthermore, microbial contamination of food items causes spoilage, which can result in foodborne illnesses if consumed. Foodborne illnesses are regarded as serious public health issues around the world.

The importance of food safety as a measure to prevent the spread of diseases is growing. In many countries, the government is significantly focusing on food-related safety standards. Regulatory authorities are constantly updating food safety regulations to ensure that the food and beverage industries deliver the optimum safety and quality of food products to consumers. Thus, the global market report is expected to grow during the forecast period.

Major Market Challenge

The inadequate healthcare services in developing regions is a major challenge to the global market. Many people in developing regions such as APAC and MEA do not have the required knowledge or access to healthcare facilities to stay healthy. Also, the lack of financial resources is a major obstacle to public health, leading to an increase in infectious diseases, which is a significant public health concern. Moreover, healthcare systems in most developing countries are plagued by a lack of skilled personnel, making it difficult for them to provide access to quality healthcare services such as rapid microbiology testing.

The stigma or misconception about the gravity of conditions such as STDs further discourages any form of testing, including microbial testing and the subsequent treatment of infectious diseases. Hence, the drawbacks of developing countries, such as the prevalence of infectious diseases causing high mortality and morbidity, lack of skilled healthcare personnel and financial resources, and inadequate infrastructure and healthcare systems that are responsive to the needs of society, will hinder the market during the forecast period.

Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their strategies.

Market Customer Landscape

Market Segmentation

The market has been segmented by method, end-user, and region. In the method segment of the market, various techniques and advancements are driving efficiency and accuracy in microbiological testing. Molecular diagnostic techniques, characterized by their rapidity and precision, are gaining prominence due to ongoing technological advancements. Conference and webinar materials serve as vital resources for disseminating knowledge about emerging microbiology techniques and best practices. These platforms facilitate discussions on buying behavior and industry trends, shaping the adoption of rapid testing solutions. Key components of rapid microbiology testing include swabs, transport media, and extraction reagents. These essential tools enable the efficient collection, preservation, and processing of microbial samples, addressing food safety concerns and supporting public-private investments in microbiological research and innovation.

By Method

The market share growth of the growth-based segment will be significant during the forecast period. Growth-based rapid microbiological testing differs from traditional culture methods in that it relies on the detection of biochemical or physiological indicators. This generally allows for much faster detection, but it frequently necessitates a brief enrichment stage before microorganisms can be detected, especially in samples with low levels of contamination.

Get a glance at the market contribution of various segments  Request Market Research Report Sample PDF

The growth-based segment was valued at USD 1.49 billion in 2017 and continued to grow until 2021. Growth-based microbiology testing can provide a quantitative cell count, an estimation of viable cell concentration, information about the presence of a specific microorganism, or microbial identification. The growth-based microbiology testing segment holds the largest market share in due to an increase in the early detection of infectious diseases, and it will continue to dominate the market during the forecast period.

Which are the Key Regions for the Market?

For more insights on the market share of various regions Request Market Research Report Sample PDF

North America is projected to hold a 41% share of the market in 2023. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. 

North America was the largest revenue contributor to the global market in 2022, with the US being the leading country. The growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several companies in the country offering a wide range of microbial testing products are aiding the market. Therefore, the increase in emphasis on the production of drugs has played a major role in the adoption of microbial testing in the region. 

Who are the Major Market Players?                                 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company offers solutions for rapid microbiology testing that includes a wide range of BACT/ALERT 3D culture media bottles adapted to the type of microbial detection performed.

The market report also includes detailed analyses of the competitive landscape and information about 15 companies, including:

• Becton Dickinson and Co.
• bioMerieux SA
• Biosensia Ltd.
• Bruker Corp.
• Charles River Laboratories
• Colifast AS
• Danaher Corp.
• Don Whitley Scientific Ltd.
• Euroclone SpA
• Gradientech AB
• Merck KGaA
• Neogen Corp.
• Quidel Corp.
• Rapid Micro Biosystems Inc.
• rqMicro AG

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is witnessing significant growth driven by advancements in molecular diagnostic techniques and automation, catering to the increasing demand for faster and more sensitive detection methods. Conference and webinar materials play a crucial role in educating stakeholders about buying behavior and the benefits of rapid testing technologies. Technological advancements such as miniaturization and improved detection sensitivity are enhancing the efficiency of microbiology testing services. Public private investments are fueling research in areas such as antimicrobial resistance and bioterrorism surveillance. Assay reagents, equipment, and extraction reagents are essential components in clinical microbiology laboratories, where routine tests using swabs and transport media are conducted. However, staffing shortages remain a challenge in ensuring the seamless operation of rapid microbiology testing facilities.

The market is experiencing significant advancements in methods and technologies, revolutionizing disease diagnosis across various sectors. With the rise of infectious diseases incidence and disease outbreaks, there's an urgent need for effective antimicrobial susceptibility testing and environmental monitoring. Rapid testing methods play a crucial role in clinical disease diagnosis, especially for conditions like anal cancer, cervical cancer, and diseases caused by human papillomavirus (HPV) such as gonorrhea and hepatitis B and C. The food and beverage industry and healthcare infrastructure heavily rely on rapid microbiology testing for ensuring safety and quality standards. However, challenges persist, including drug resistance patterns and staffing shortages in laboratory infrastructure, impacting healthcare expenditure and Medicare.

The market is witnessing a surge in demand for advanced methods and instruments to combat infectious diseases effectively. With a focus on public health, rapid testing plays a crucial role in detecting pathogens like Chlamydia and Listeria swiftly. Cosmetics and industrial testing sectors are increasingly adopting rapid microbiology testing to ensure product safety and quality. Healthcare spending continues to prioritize efficient diagnostic solutions, especially for identifying High risk (HR) HPV genotypes and Low risk (LR) HPV genotypes linked to cervical cancer. Accessible consumables and robust medical infrastructures facilitate widespread implementation of rapid testing methods, offering timely detection of etiologic agents and enhancing healthcare outcomes globally.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

• Method Outlook 
  • Growth-based
  • Nucleic-acid based
  • Viability-based
  • Others

• End-user Outlook 
  • Hospitals and diagnostic laboratories
  • Pharmaceutical and biotechnology companies
  • Others

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Australia
    • Argentina
    • Rest of the World

Market Scope
Report Coverage	Details
Page number	156
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 9.31%
Market growth 2023-2027	USD 2.48 billion
Market structure	Fragmented
YoY growth (%)	9.07
Regional analysis	North America, Asia, Europe, and Rest of World (ROW)
Performing market contribution	North America at 41%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks
Key companies profiled	Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Biosensia Ltd., Bruker Corp., Charles River Laboratories, Colifast AS, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, Gradientech AB, Merck KGaA, Neogen Corp., Quidel Corp., Rapid Micro Biosystems Inc., rqMicro AG, Sartorius AG, Serosep Ltd., Solus Scientific Ltd., and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request Market Research Report Sample PDF

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

 

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch